Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Restenosis after angioplasty.

¹Division of Cardiovascular Medicine, University of Florida College of Medicine.

Medical Section Proceedings : the ... Annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. Meeting

|January 1, 1991

Summary

Restenosis after coronary angioplasty is a proliferative lesion of vascular smooth muscle cells, often occurring in specific lesion types and locations. Angiography defines restenosis, with repeat dilation as the current treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Arterial stiffness assessment in coronary microvascular dysfunction and heart failure with preserved ejection fraction: An initial report from the WISE-CVD continuation study.

American heart journal plus : cardiology research and practice·2024

Same author

Coronary atheroma burden predicts flow reserve in women with ischemia and nonobstructive coronary artery disease.

American heart journal plus : cardiology research and practice·2024

Same author

Cold Pressor Testing and Sympathetic Nervous System Contribution to Ischemia with No Obstructive Coronary Artery Disease: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Project.

American heart journal plus : cardiology research and practice·2022

Same author

Genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes.

The pharmacogenomics journal·2016

Same author

Five-year stroke rate in women with signs and symptoms of ischemia undergoing coronary angiography: a retrospective study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).

JRSM open·2015

Same author

Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatment.

The pharmacogenomics journal·2012

Area of Science:

Cardiovascular Medicine
Interventional Cardiology

Background:

Restenosis remains a significant complication following coronary angioplasty.
The underlying mechanism is theorized to involve vascular smooth muscle cell proliferation.

Purpose of the Study:

To discuss the current understanding of restenosis after coronary angioplasty.
To identify risk factors and define restenosis.

Main Methods:

Literature review and theoretical discussion on restenosis.
Analysis of lesion characteristics and procedural factors associated with restenosis.
Emphasis on angiographic definition of restenosis.

Main Results:

Restenosis is characterized by vascular smooth muscle cell proliferation, obliterating the lumen 3-6 months post-angioplasty.
High-risk factors include proximal lesions, long lesions, severe stenosis, incomplete dilation, and small arteries.
Approximately one-third of successful angioplasty patients experience restenosis, with one-third asymptomatic.

Conclusions:

Restenosis is primarily a proliferative lesion driven by vascular smooth muscle cells.
Specific lesion and procedural factors, not patient factors, predict restenosis risk.
Angiography is the definitive diagnostic method; repeat dilation is the current treatment.

Related Experiment Videos